The birthplace of the Unither group and the implementation of Blow-Fill-Seal (BFS) technology, the Amiens site develops and manufactures sterile single doses to address market needs in rhinology, asthma, ophthalmology, and antisepsis.
With the construction of a new building designed to accommodate its new Euroject® technology, the site will allow the production of vaccines and biological products, thus confirming its driving role in the Group’s diversification.
438
employees
1.6 billion
single doses/year
500 million
doses of vaccines ultimately (Euroject®)
80 countries
where products manufactured for our clients are distributed
Sterile single doses (Blow-Fill-Seal): rhinology, asthma, ophthalmology, antisepsis
Blow-Fill-Seal for injection (Euroject®): vaccines, biological products (BSL2), and thermosensitive products.
Authorizations:
– EMA (Europe),
– ANSM (France),
– as well as other authorities (Libya, Ukraine, etc.)
Standards and certifications:
– cGMP (Europe)
– ISO 13485:2016 – Medical Devices (GMED / LNE)
– Research Tax Credit (CIR)
– ISO 50001
Address:
Unither Amiens Site
151, André Durouchez Street
North Industrial Area
CS 28028
80084 Amiens Cedex 2
France
Contact:
Phone: +33 (0)3 22 54 73 00
Fax: +33 (0)3 22 54 73 10
Email: contact@unither-pharma.com
How to get here:
By road: from Paris, A1 then A29 superhighway (approx. 150 km)
By train: Amiens station (1 hr 10 min from Paris Gare du Nord)
By plane: Paris-Charles de Gaulle (125 km) or Beauvais-Tillé (60 km) airports
